OCONNOR, A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS (LLC) - LEXICON PHARMACEUTICALS INC ownership

LEXICON PHARMACEUTICALS INC's ticker is and the CUSIP is 528872AB0. A total of 12 filers reported holding LEXICON PHARMACEUTICALS INC in Q2 2016. The put-call ratio across all filers is - and the average weighting 0.8%.

Quarter-by-quarter ownership
OCONNOR, A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS (LLC) ownership history of LEXICON PHARMACEUTICALS INC
ValueSharesWeighting
Q4 2016$21,586,000,000
-20.4%
12,000,0000.0%0.42%
+3.5%
Q3 2016$27,118,000,000
+20.4%
12,000,0000.0%0.40%
-17.1%
Q2 2016$22,523,000,000
+64.2%
12,000,000
+41.2%
0.49%
+92.9%
Q1 2016$13,714,000,000
-8.3%
8,500,0000.0%0.25%0.0%
Q4 2015$14,952,000,0008,500,0000.25%
Other shareholders

There were no reported owners of LEXICON PHARMACEUTICALS INC in Q2 2016.

NameSharesValueWeighting ↓
View complete list of LEXICON PHARMACEUTICALS INC shareholders